Context Therapeutics | ApexOnco - Clinical Trials news and analysis

x

“The insights provided by the analysts are great”

Andrea Gnirke-Maier

Director New Product Planning

Morphosys

Click here for more information

Deals

24 September 2024

Context could herald what’s next for Nectin-4

Data insights

6 August 2024

Nuvalent’s next battleground is HER2

NVL-330 features among the latest crop of industry projects newly into human trials.

Regulatory

10 July 2024

Amgen packs up in Claudin6

Meanwhile, Torl BioTherapeutics appears to be catching up with BioNTech.

Subscribe to Context Therapeutics